Anaphylactic reaction during the perioperative period typically exhibits rapid onset, varying clinical manifestations, and an expected mortality rate of 1.5-9%. Neuromuscular blocking agents are the leading cause of perioperative anaphylaxis. Here, we report a severe case of anaphylaxis that developed in a 66-year-old man due to cisatracurium administration. And he was successfully managed by extracorporeal membrane oxygenation. Cardiopulmonary resuscitation was performed by extracorporeal membrane oxygenation, and the patient was successfully weaned off 24 hours later.
The patient was finally diagnosed with anaphylactic shock due to cisatracurium (a tetrahydroisoquinoline derivative).
He was fully informed of the results and returned 4 weeks later for a laparoscopy distal gastrectomy under general anesthesia with vecuronium, fentanyl, and etomidate. This surgery was uneventful.
Discussion
The estimated incidence of intraoperative anaphylaxis ranges between 1of 3,500-20,000 patients , and an estimated mortality rate of 1.5-9% has been reported. The severity of intraoperative anaphylaxis is classified into four levels according to symptoms and signs: grade I, generalized cutane- [7] Sadleir et al [3] recently reported that 14% and 68% of intraoperative anaphylaxis events were grade 4 and 3, respectively.
Anaphylaxis is initiated by the degranulation of mast cells or basophiles, regardless of the immunological or nonimmunological triggering mechanism, and releases various mediators such as histamine and tryptase. IgE-mediated (i.e., immunological) anaphylaxis typically presents with more severe manifestations than non-immune-mediated anaphylactic reactions, even if they are clinically indistinguishable. [7] Laboratory testing for serum tryptase, which has a 90-minute half-life and can be detected at ≥ 6 hours after anaphylaxis, is often used to confirm the diagnosis of immune-mediated anaphylaxis. [8] NMBAs are the leading cause, and are responsible for 60-70% of perioperative anaphylactic reactions. Previous exposure is not necessary for an anaphylactic response to NMBAs, and approximately 15% of affected patients develop reactions at the first known contact. [9] Cross-reactivity to the tertiary and quaternary ammonium ions, which are the main components of the antigenic determinants of NMBAs, has been suggested as the triggering reaction. [10] Here, severe grade IV anaphylaxis developed during anesthesia in a 66-year old man with no previous exposure to NMBAs. IgE-mediated anaphylaxis to cisatracurium was confirmed by laboratory and skin tests in this case.
Managing general anaphylaxis involves airway patency maintenance, proper fluid therapy, the administration of epinephrine and vasoactive drugs such as noradrenaline, metaraminol, glucagon, and vasopressin in order to restore cardiovascular homeostasis. [7] With recent technological advances, various attempts have been made to increase the survival rate following cardiac arrest in intensive care units.
Using ECMO to treat cardiac arrest in adults, also known as E-CPR, is one such approach. According to recent studies, E-CPR should increase the chance of survival and hospital discharge following cardiac arrest. To shortening of ECMO deployment time was recommedated to improve the survival. [11] In our current case, anaphylaxis led to the abrupt development of cardiac arrest while performing general management for anaphylaxis including fluid infusion, epinephrine and vasoactive drug. The patient was required more expeditious cardiopulmonary resuscitation. We expected repeated ventricular fibrillation and pulseless electrical activity to lead to death. ECMO was urgently initiated, and CPR was terminated after 35 minutes. Cardiovascular hemostasis recovered after ECMO was applied. Lafforque E. et al [12] reported that successful extracorporeal resuscitation of a anaphylactic shock. They described the anaphylactic shock with cardiac arrest was unresponsed to CPR during 60 mintues and recoveried after E-CPR.
As we used prepared ECMO which was previously primed of circuit, we shortened the time of ECMO established and CPR. We think that ECMO is a valuable method for managing severe anaphylaxis in patients who are unresponsive to general resuscitation. And in order to minimize the deployment time of ECMO support in critically conditions, it is need preparation like previously primed circuit of ECMO.
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